Pancreatic Cancer :: Transforming Early Detection & Treatment with Experts at NYU Langone Health |Webinar

Recorded Live 12:00PM, November 20, 2020

The 5-year survival rate for patients with pancreatic cancer is about 9%, at least in part because the disease has typically spread to other organs by the time it is diagnosed.

Under the guidance of Dr. Diane M. Simeone, Director of NYU Langone Health’s Pancreatic Cancer Center, NYU Langone serves as the coordinating center for the newly formed PRECEDE (Pancreatic Cancer Early Detection) Consortium, a collaboration of 35 academic centers around the world focused on early detection in familial high-risk individuals.

As a leader in Preventive Medicine and Executive Health, Princeton Longevity Center invites you to join our LIVE Webinar with expert Dr. Simeone who will provide understanding on Pancreatic Cancer Risk Factors, Genetic Predisposition and Effective Screening Protocols for those at the highest risk.

TOPICS TO INCLUDE:
– Identification of Patients at High Risk for Pancreatic Cancer
– Who Should Get Germline Testing for Pancreatic Cancer Suspectibility Genes
– Known Genes/Cancer Syndromes that are Linked to Pancreatic Cancer
– Cost and Availability of Genetic Testing
– Data Showing Benefit of Pancreas Surveillance in People at High Risk
– Discussion of Modalities, Non-Invasive Technologies and strategies for screening/imaging the pancreas